Insigneo Advisory Services, LLC Bristol Myers Squibb CO Transaction History
Insigneo Advisory Services, LLC
- $968 Billion
- Q4 2024
A detailed history of Insigneo Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Insigneo Advisory Services, LLC holds 6,609 shares of BMY stock, worth $368,716. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,609
Previous 14,064
53.01%
Holding current value
$368,716
Previous $728 Million
48.63%
% of portfolio
0.04%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.85 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.36 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...